BridgeMD
New treatment option for Foot Injuries and Disorders
Official title Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
ClinicalTrials.gov ID: NCT06780202
What this study is testing
What is medrol dosepak?
medrol dosepak is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for foot injuries and disorders.
Also referred to as Methylprednisolone.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries. The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 95
You may be able to join if
- -Emory Orthopedic patients undergoing foot and ankle surgery
You likely can't join if
- Concurrent or significant injuries to other bones or organs
- Local infections
- History of alcohol or medical abuse, including prior opioid abuse
- Smoking
- History of severe heart disease, renal failure, liver dysfunction, active peptic ulcer disease, diabetes, rheumatoid arthritis, neurological or...
- Pre-existing immune suppression
See the full eligibility criteria
- -Emory Orthopedic patients undergoing foot and ankle surgery
- Concurrent or significant injuries to other bones or organs
- Local infections
- History of alcohol or medical abuse, including prior opioid abuse
- Smoking
- History of severe heart disease, renal failure, liver dysfunction, active peptic ulcer disease, diabetes, rheumatoid arthritis, neurological or psychiatric diseases that could influence pain perception
- Pre-existing immune suppression
- Those deemed possibly non-compliant by the study team and,
- All vulnerable populations (those unable to give consent, juveniles, pregnant women, prisoners, cognitively impaired and non-English speaking).
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
- Johns Creek, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States; Johns Creek, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.